Dudley Robinson The term stress urinary incontinence (SUI) may be used to describe the symptom or sign of urinary leakage on coughing or exertion but should not be regarded as a diagnosis. A diagnosis of urodynamic stress incontinence (USI) can only be made after urodynamic investigation, and this is defined as the involuntary leakage of urine during increased abdominal pressure in the absence of a detrusor contraction. All women who complain of the symptom of SUI will initially benefit from lifestyle advice and pelvic floor muscle training (PFMT). Those who fail to improve with conservative measures may benefit from Duloxetine or may ultimately require continence surgery. This chapter will focus on those surgical options that may be performed as ambulatory or outpatient procedures. Stress incontinence is the most commonly reported type of urinary incontinence in women. In a large epidemiological study of 27 936 women from Norway, 25% of women reported urinary incontinence of whom 7% considered it to be significant. The prevalence of incontinence increased with age. When considering the type of incontinence, 50% of women complained of stress, 11% of urge, and 36% of mixed incontinence. The prevalence of urinary incontinence among nulliparous women ranged from 8 to 32% and increased with age. In general, parity was associated with incontinence and the first delivery was the most significant factor. In the age group 20–34 years, the relative risk of stress incontinence was 2.7 (95% CI: 2.0–3.5) for primiparous women and 4.0 (95% CI: 2.5–6.4) for multiparous women. There was a similar association for mixed incontinence, although, not for urge incontinence. There are various underlying causes that result in weakness of one or more of the components of the urethral sphincter mechanism (Table 7.1). Table 7.1 Causes of stress urinary incontinence. The bladder neck and proximal urethra are normally situated in an intra‐abdominal position above the pelvic floor and are supported by the pubo‐urethral ligaments. Damage to either the pelvic floor musculature (levator ani) or pubo‐urethral ligaments may result in descent of the proximal urethra such that it is no longer an intra‐abdominal organ and this results in leakage of urine per urethra during stress. This theory has given rise to the concept of the ‘hammock hypothesis,’ which suggests that the posterior position of the vagina provides a backboard against which increasing intra‐abdominal forces compress the urethra. This is supported by the fact that continent women experience an increase in intra‐urethral closure pressure during coughing. This pressure rise is lost in women with stress incontinence, although, may be restored following successful continence surgery. In addition to pelvic floor damage, there is also evidence to suggest that stress incontinence may be caused by primary urethral sphincter weakness or intrinsic sphincter deficiency (ISD). In order to distinguish this type of stress incontinence from that caused by descent and rotation of the bladder neck during straining, the Blaivis Classification has been described based on video‐cystourethrography observations. This proposes that Type I and Type II stress incontinence are caused principally by urethral hypermobility, whereas Type III, or ISD, is caused by a primary weakness in the urethral sphincter. Factors associated with ISD are pudendal denervation injuries, loss of integrity of the striated urethral sphincter and urethral smooth muscle, as well as the loss of urethral mucosa and submucosal urethral cushions. The ‘mid‐urethral theory’ or ‘integral theory’ described by Petros and Ulmsten is based on earlier studies suggesting that the distal and mid‐urethra play an important role in the continence mechanism and that the maximal urethral closure pressure is at the mid urethral point. This theory proposes that damage to the pubourethral ligaments supporting the urethra, impaired support of the anterior vaginal wall to the mid urethra and weakened function of part of the pubococcygeal muscles, which insert adjacent to the urethra, are responsible for causing stress incontinence. The acceptance of the ‘Integral Theory’ of incontinence and the success of mid‐urethral sling surgery has transformed the approach to continence surgery. There has been a shift from more traditional procedures such as colposuspension and autologous fascial slings, which required an in‐patient stay, to day‐case procedures. Minimally invasive surgery is associated with less morbidity and considerable cost savings. This had led to a move towards minimally invasive procedures performed as a day‐care procedure in an ambulatory setting (Table 7.2). Table 7.2 Ambulatory procedures for stress urinary incontinence. Urethral bulking agents may be performed in the ambulatory clinic under local anaesthetic. They are particularly useful in younger women who haven’t yet completed their families, in the elderly with co‐morbidities, and in those women, who have undergone previous operations and have demonstrated ISD. Although the actual substance that is injected may differ, the principle is the same. It is injected either periurethrally or transurethrally on either side of the bladder neck or mid‐urethra under cystoscopic control. It is intended to increase urethral coaptation without causing out‐flow obstruction. There are now a number of different products available (Table 7.3). The use of minimally invasive implantation systems has also allowed some of these procedures to be performed in the ambulatory setting without the need for concomitant cystoscopy. Table 7.3 Urethral bulking agents.
7
Ambulatory Surgical Procedures in Stress Urinary Incontinence
Introduction
Epidemiology
Pathophysiology
Urethral hypermobility
Urogenital prolapse
Pelvic floor damage or denervation
Parturition
Pelvic surgery
Menopause
Urethral scarring
Vaginal (urethral) surgery
Incontinence surgery
Urethral dilatation or urethrotomy
Recurrent urinary tract infections
Radiotherapy
Raised intra‐abdominal pressure
Pregnancy
Chronic cough (bronchitis)
Abdominal/pelvic mass
Faecal impaction
Ascites
(Obesity)
Ambulatory Procedures for Stress Urinary Incontinence
Urethral Bulking Agents
Single Incision Mini‐Slings
Laser Therapy
Radiofrequency Ablation
Urethral Bulking Agents
Urethral Bulking Agent
Application Technique
Polydimethylsiloxane
(Macroplastique)
Cystoscopic
Implantation System
Pyrolytic carbon coated zirconium oxide beads
(Durasphere)
Cystoscopic
Calcium Hydroxylapatite in carboxymethylcellulose gel
(Coaptite)
Cystoscopic
Polyacrylamide hydrogel
(Bulkamid)
Cystoscopic
Vinyl Dimethyl Polydimethylsiloxane (PDMS) Polymer
(Urolastic)
Implantation System
Polycaprolactone (PCL)
(Urolon)
Cystoscopic